Simone Bertz Selected Research

Non-Muscle Invasive Bladder Neoplasms

10/2020	Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.
1/2018	CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simone Bertz Research Topics

Disease

28	Neoplasms (Cancer) 11/2021 - 01/2009
23	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 08/2010
12	Carcinoma (Carcinomatosis) 01/2021 - 06/2009
3	Lymphatic Metastasis 10/2013 - 04/2011
2	Microsatellite Instability 09/2021 - 01/2019
2	Non-Muscle Invasive Bladder Neoplasms 10/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 04/2019 - 04/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2013 - 01/2012
2	Prostatic Neoplasms (Prostate Cancer) 09/2009 - 04/2009
2	Body Weight (Weight, Body) 09/2009 - 06/2009
2	Margins of Excision 09/2009 - 06/2009
1	Inflammation (Inflammations) 01/2022
1	Multiple Myeloma 01/2022
1	Paraproteinemias (Monoclonal Gammopathy) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Turcot syndrome 11/2021
1	Colonic Neoplasms (Colon Cancer) 11/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Cytomegalovirus Infections (Inclusion Disease) 01/2020
1	Pain (Aches) 01/2020
1	Hyperthermia 12/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Polyps 01/2019
1	Carcinoma in Situ 03/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2012
1	Transitional Cell Carcinoma 04/2011
1	Blastomycosis 01/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2009

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2013
5	Phenobarbital (Luminal)FDA Link 11/2021 - 12/2019
4	Cisplatin (Platino)FDA LinkGeneric 04/2014 - 08/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2014
3	Biological ProductsIBA 12/2019 - 01/2012
3	ParaffinIBA 10/2013 - 08/2010
3	Formaldehyde (Formol)FDA Link 10/2013 - 08/2010
2	B7-H1 AntigenIBA 11/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 11/2021 - 04/2014
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
2	Keratins (Keratin)IBA 12/2020 - 04/2009
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 01/2018
2	PlatinumIBA 01/2020 - 12/2019
2	Cadherins (E-Cadherin)IBA 03/2017 - 07/2013
2	AcidsIBA 09/2009 - 06/2009
1	AntibodiesIBA 11/2021
1	LigandsIBA 01/2021
1	NucleotidesIBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Calcineurin InhibitorsIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Membrane Cofactor ProteinIBA 01/2020
1	Kisspeptin-1 ReceptorsIBA 04/2019
1	A-Form DNA (A-DNA)IBA 04/2019
1	pembrolizumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	atezolizumabIBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Ribonuclease III (RNase III)IBA 01/2019
1	Fibroblast Growth Factor 3IBA 01/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 09/2016
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	Cystine (L-Cystine)IBA 04/2014
1	Trypsin InhibitorsIBA 03/2014
1	AminopeptidasesIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Retinoblastoma ProteinIBA 12/2012
1	Protein Isoforms (Isoforms)IBA 04/2011
1	Transcription Factors (Transcription Factor)IBA 04/2011
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2010
1	Epirubicin (Ellence)FDA LinkGeneric 08/2010
1	Methotrexate (Mexate)FDA LinkGeneric 08/2010
1	protoporphyrin IXIBA 06/2009
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2009

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2009
11	Cystectomy 01/2022 - 12/2012
9	Drug Therapy (Chemotherapy) 01/2021 - 04/2011
5	Adjuvant Chemotherapy 01/2021 - 08/2010
2	Transurethral Resection of Bladder 10/2020 - 12/2019
2	Aftercare (After-Treatment) 01/2020 - 09/2016
2	Radiotherapy 12/2019 - 12/2012
2	Chemoradiotherapy 12/2019 - 09/2016
2	Prostatectomy (Retropubic Prostatectomy) 09/2009 - 06/2009
1	Renal Dialysis (Hemodialysis) 01/2020
1	Immunotherapy 01/2020
1	Combined Modality Therapy 12/2019
1	Lymph Node Excision (Lymph Node Dissection) 12/2019
1	Lasers (Laser) 08/2010
1	Extracorporeal Membrane Oxygenation 01/2009